Adjuvant 5-fluorouracil plus levamisole in colon cancer: the plot thickens?
Open Access
- 1 June 1994
- journal article
- editorial
- Published by Springer Nature in British Journal of Cancer
- Vol. 69 (6) , 986-987
- https://doi.org/10.1038/bjc.1994.193
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Late mortality and levamisole adjuvant therapy in colorectal cancerBritish Journal of Cancer, 1994
- Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy.Journal of Clinical Oncology, 1993
- The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.Journal of Clinical Oncology, 1993
- Effect of levamisole on major histocompatibility complex class I expression in colorectal and breast carcinoma cell linesCancer, 1993
- Multifocal Leukoencephalopathy: Occurrence During 5-Fluorouracil and Levamisole Therapy and Resolution After Discontinuation of ChemotherapyMayo Clinic Proceedings, 1993
- Dose-related immunologic effects of levamisole in patients with cancer.Journal of Clinical Oncology, 1993
- Levamisole in the treatment of cancer: anything new? (Review).1992
- Levamisole: known effects on the immune system, clinical results, and future applications to the treatment of cancer.Journal of Clinical Oncology, 1991
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Adjuvant therapy of colorectal cancer. Why we still don't know.1988